Chinese health biotech and the billion-patient market

Nat Biotechnol. 2008 Jan;26(1):37-53. doi: 10.1038/nbt0108-37.

Abstract

Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits.

Supplementary information: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomedical Technology / trends*
  • Biotechnology / trends*
  • China
  • Delivery of Health Care / trends*
  • Drug Industry / trends*
  • Marketing of Health Services / trends*